AtriCure (NASDAQ:ATRC) Research Coverage Started at JMP Securities

JMP Securities started coverage on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report released on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $60.00 price target on the medical device company’s stock. Several other research analysts also recently commented on the company. BTIG Research boosted their target price […]

Leave a Reply

Your email address will not be published.

Previous post Editorial: Standing up, speaking out against Hamas terror
Next post Startek (NYSE:SRT) Coverage Initiated by Analysts at